drugset / Trial / NCT06049342
A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA
Phase 1
Unknown
12 enrolled
Nuwacell Biotechnologies Co., Ltd.
Beijing Luhe Hospital · collabShanghai 6th People's Hospital · collab
NaSequentialOpen-labelTreatment
Summary
This clinical study is to investigate the safety and efficacy of NCR100 injection in subjects with knee osteoarthritis (KOA). It is a dose-escalating, open label study in adult KOA subjects.
Timeline
- Start
- 2024-01-25
- Primary completion
- 2024-06
- Completion
- 2025-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NCR100 | Cell therapy | — | Other |